A Phase 3, Multicenter, Open-Label, Single-Arm Study of PB2452 in Ticagrelor-Treated Patients with Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure

Clinical Trial Grant

Duke Scholars

William Raymond Herzog

Principal Investigator William Raymond Herzog Medicine, Cardiology

Administered By

Institutes and Centers

Awarded By

PhaseBio Pharmaceuticals, Inc.

Start Date

November 23, 2020

End Date

March 14, 2023

Administered By

Institutes and Centers

Awarded By

PhaseBio Pharmaceuticals, Inc.

Start Date

November 23, 2020

End Date

March 14, 2023